Search

everythinglearnresearchcommunity

for

Search:↓

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Some blood thinners can cause hair loss, but switching medications can stop it.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Sunlight exposure damages hair follicles, but certain stem cell-derived particles can reduce this damage and help with hair regeneration.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Dutasteride for hair loss might increase the risk of a rare stroke type.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

High-frequency ultrasound can effectively visualize and assess hair loss.

Genetics and hormones cause hair loss; finasteride treats it safely.

Growth factors are crucial for hair development and could help treat hair diseases.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Some psychiatric medications can cause hair loss, but it usually grows back after adjusting the medication.

Modified stem cells from umbilical cord blood can make hair grow faster.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Venlafaxine can cause hair loss, which stops after discontinuation.